Verition Fund Management
DFTX

Verition Fund Management’s Definium Therapeutics DFTX Stock Holding History

Verition Fund Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,384
Closed -$196K – 2361
2026
Q1 		$196K Sell
10,384
-121,879
-92% -$2.07M ﹤0.01% 1955
2025
Q4 		$1.77M Buy
+132,263
New +$1.64M 0.01% 1720

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Verition Fund Management's DFTX Position: Q2 2026 in Review

Verition Fund Management sold out of Definium Therapeutics (DFTX) in Q2 2026, closing a stake of 10,384 shares — an estimated $196K sold.

Verition Fund Management first reported a position in DFTX in Q4 2025 and held it in 2 quarters. The position peaked at $1.77M in Q4 2025. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Verition Fund Management reported no remaining Definium Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Verition Fund Management sold 10,384 Definium Therapeutics shares in Q2 2026, an estimated $196K.
  • Verition Fund Management first reported a position in Definium Therapeutics in Q4 2025 and held it in 2 quarters.
  • Verition Fund Management's Definium Therapeutics position peaked at $1.77M in Q4 2025.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.